L-156602
Product Specifications
UNSPSC Description
L-156602 is a C5a receptor antagonist. L-156602 inhibits inflammation, and the migration of monocytes and neutrophils to the infiltrating site in mouse inflammatory models. L-156602 suppresses the efferent phase of delayed-type hypersensitivity (DTH)[1][2].
Target Antigen
Complement System
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/l-156602.html
Solubility
10 mM in DMSO
Smiles
CC[C@@H](C[C@H]1CC[C@@]([C@@](C(N[C@H]2[C@H](C(C)C)OC([C@@H](C)N(O)C([C@H]3CCCNN3C(CNC([C@H](C)N(O)C([C@@H]4CCCNN4C2=O)=O)=O)=O)=O)=O)=O)(O)C)(O)O[C@@H]1C)C
Molecular Weight
840.96
References & Citations
[1]Tsuji RF, et al. Effects of L-156,602, a C5a receptor antagonist, on mouse experimental models of inflammation. Biosci Biotechnol Biochem. 1992 Dec;56(12):2034-6.|[2]Tsuji RF, et al. Anti-inflammatory effects and specificity of L-156,602: comparison of effects on concanavalin A and zymosan-induced footpad edema, and contact sensitivity response. Immunopharmacology. 1995 Feb;29(1):79-87.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-16384/L-156602-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-16384/
Clinical Information
No Development Reported
CAS Number
125228-51-5
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1054876-01 0.02 mg (E-Coli)
Recombinant Salmonella newport Phosphopentomutase (deoB)
Ask
View Details MBS1054876-02 0.02 mg (Yeast)
Recombinant Salmonella newport Phosphopentomutase (deoB)
Ask
View Details MBS1054876-03 0.1 mg (E-Coli)
Recombinant Salmonella newport Phosphopentomutase (deoB)
Ask
View Details 
MBS1054876-04 0.1 mg (Yeast)
Recombinant Salmonella newport Phosphopentomutase (deoB)
Ask
View Details